REFERENCES
- Erishefsky L: Pharmacological profile of risperidone. Can J Psychiatry 1993; 38 (Suppl 3):S80–S88
- Borison RL, Pathiraja AE Diamond BI, Meibach RC: Ris-peridone: Clinical safety and efficacy in schizophrenia. Psy-chopharmacol Bull 1992; 28:213–218
- Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labella A, Beauclair L, Arnott W: A Ca-nadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia. J Clin Psychopharmacol 1993; 13:25–40
- Addington DE, Jones B, Bloom D, Chouinard G, Remington G, Albright P: Reduction of hospital days in chronic schizo-phrenic patients treated with risperidone. A retrospective study. Excerpta Medica 1993; 15:917–926
- Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151:825–835
- Jones B, De Smedt G, Lemmens P: Therapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia. In: International Academy for Biomedical and Drug Research Meeting, Florence, Italy, March 10–12, 1995